WHOCC
Postal address:
WHO Collaborating Centre for Drug Statistics Methodology
Norwegian Institute of Public Health
Postboks 222 Sk°yen
0213 Oslo
Norway

Visiting/delivery address:
Myrens verksted 6H
0473 Oslo
Norway

Tel:  +47 21 07 81 60
E-mail:
 
Copyright/Disclaimer

New search    Hide text from Guidelines

C CARDIOVASCULAR SYSTEM

This group comprises substances used for the treatment of cardiovascular conditions.
Drugs used for the treatment of hypertension are classified in C02 - Antihypertensives, C03 - Diuretics, C07 - Beta blocking agents, C08 - Calcium channel blockers, and C09 - Agents acting on the renin-angiotensin system. For the classification of combination products of antihypertensives from different ATC groups, the following ranking should be used, from higher to lower precedence: C09, C07, C08, , and C03.


C09 AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM

The DDDs are based on the treatment of mild-moderate hypertension.
See comments to C02L concerning the principles for assignment of DDDs for combined preparations.


C09A ACE INHIBITORS, PLAIN

All plain ACE inhibitors are classified in this group. No separate ATC codes are assigned for the active metabolites of the ACE inhibitors (e.g. enalaprilat, quinaprilat).
Combinations with diuretics, see C09BA - ACE inhibitors and diuretics.
Combinations with calcium channel blockers, see C09BB - ACE inhibitors and calcium channel blockers.
Combinations with beta blocking agents, see C09BX - ACE inhibitors, other combinations.


C09AA ACE inhibitors, plain

Last updated: 2023-01-23